Methods of treatment using intravenous formulations comprising temozolomide

Details for Australian Patent Application No. 2008251921 (hide)

International Classifications

Event Publications

24 December 2009 PCT application entered the National Phase

PCT publication WO2008/140724 Priority application(s): WO2008/140724

7 January 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 30 Nov 2009

4 October 2012 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.